Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes
Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V. Matveyenko, David Kirakossian, David W. Dawson, Sarah M. Dry, Peter C. Butler, Alexandra E. Butler
Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V. Matveyenko, David Kirakossian, David W. Dawson, Sarah M. Dry, Peter C. Butler, Alexandra E. Butler
View: Text | PDF
Research Article Endocrinology

Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes

  • Text
  • PDF
Abstract

Pancreatitis is more frequent in type 2 diabetes mellitus (T2DM), although the underlying cause is unknown. We tested the hypothesis that ongoing β cell stress and apoptosis in T2DM induces ductal tree proliferation, particularly the pancreatic duct gland (PDG) compartment, and thus potentially obstructs exocrine outflow, a well-established cause of pancreatitis. PDG replication was increased 2-fold in human pancreas from individuals with T2DM, and was associated with increased pancreatic intraepithelial neoplasia (PanIN), lesions associated with pancreatic inflammation and with the potential to obstruct pancreatic outflow. Increased PDG replication in the prediabetic human-IAPP-transgenic (HIP) rat model of T2DM was concordant with increased β cell stress but preceded metabolic derangement. Moreover, the most abundantly expressed chemokines released by the islets in response to β cell stress in T2DM, CXCL1, -4, and -10, induced proliferation in human pancreatic ductal epithelium. Also, the diabetes medications reported as potential modifiers for the risk of pancreatitis in T2DM modulated PDG proliferation accordingly. We conclude that chronic stimulation and proliferation of the PDG compartment in response to islet inflammation in T2DM is a potentially novel mechanism that serves as a link to the increased risk for pancreatitis in T2DM and may potentially be modified by currently available diabetes therapy.

Authors

Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V. Matveyenko, David Kirakossian, David W. Dawson, Sarah M. Dry, Peter C. Butler, Alexandra E. Butler

×

Figure 1

Pancreatic intraepithelial neoplasia (PanIN) lesions are more frequent in type 2 diabetes mellitus (T2DM).

Options: View larger image (or click on image) Download as PowerPoint
Pancreatic intraepithelial neoplasia (PanIN) lesions are more frequent i...
(A–D) Examples of PanIN lesions identified in individuals with T2DM (A: donor 6108, low-grade PanIN; B: donor 6114, low-grade PanIN; C: donor 6142, low-grade PanIN, D: donor 6139, low-grade PanIN; all images acquired with a ×20 lens [×200 magnification]) stained with Alcian blue to detect mucin deposition, and for insulin (pink) and Ki67 (brown) to mark replicating cells. Scale bars: 50 μm. (E) Low-grade PanIN lesions were more frequent in T2DM (14 donors; n = 42 pancreas sections [14 head, 14 body, and 14 tail]) compared with nondiabetic (ND) controls (13 donors, n = 33 pancreas sections [13 head, 7 body and 13 tail]): 4.2 ± 1.4 vs. 1.1 ± 0.6 PanIN lesions/mm2 pancreas × 103, T2DM vs. ND; *P < 0.05. Open circles = ND donors, black squares = T2DM donors. (F) There was no relationship between PanIN lesions and BMI in either the ND controls (linear regression r = 0.22, P = 0.22; n = 33) or the subjects with T2DM (linear regression r = 0.05, P = 0.77; n = 42). Open circles = ND donors, black squares = T2DM donors. Data represent mean ± SEM; 1-tailed Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts